Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Sera Prognostics's peak revenue was $306.0K in 2023. The peak quarterly revenue was $24.0K in 2024(q4).
Sera Prognostics's revenue increased from $25.0k in 2020 to $77.0K currently. That's a 208.0% change in annual revenue.
| Fiscal year / year | Sera Prognostics revenue |
|---|---|
| 2020 | $25,000 |
| 2021 | $82,000 |
| 2022 | $268,000 |
| 2023 | $306,000 |
| 2024 | $77,000 |
Rate Sera Prognostics' financial transparency
Sera Prognostics saw the greatest revenue growth in 2021, when revenue increased by 228.0%.
Sera Prognostics had the lowest revenue growth in 2022, when revenue changed by 226.83%.
| Year | Sera Prognostics growth |
|---|---|
| 2021 | 228%↑ |
| 2022 | 227%↑ |
| 2023 | 14%↑ |
| 2024 | -75%↓ |
Do you work at Sera Prognostics?
Is Sera Prognostics transparent about its revenue structure?
Sera Prognostics received early financing of $1.4M on 2011-01-04.
| Series | Round size | Date |
|---|---|---|
| Series A | $1.4M | 01/2011 |
| Series A | $19.3M | 11/2011 |
| Private Equity | $10.2M | 11/2012 |
| Series Unknown | $4.5M | 03/2014 |
| Series Unknown | $9.2M | 06/2014 |
| Series B | $5M | 11/2014 |
| Series B | $20M | 01/2015 |
| Series C | $22M | 01/2017 |
| Series Unknown | $22.7M | 01/2017 |
| Series D | $36M | 11/2019 |
| Series E | $100M | 04/2021 |
| Investors | Security type |
|---|---|
| Upstart Capital | Series A |
| Excelestar Ventures LLC | Series A |
| Catalyst Health Ventures | Series A |
| Upstart Capital | Series A |
| Osage Partners | Series A |
| InterWest Partners | Series A |
| Domain Associates | Series A |
| Catalyst Health Ventures | Series A |
| Upstart Life Ventures | Series B |
| Chione | Series B |
| Domain Associates | Series B |
| Catalyst Health Ventures | Series B |
| Upstart Life Ventures | Series B |
| Chione | Series B |
| InterWest Partners | Series B |
| Domain Associates | Series B |
| Catalyst Health Ventures | Series B |
| Catalyst Health Ventures | Series C |
| BLUE OX HEALTHCARE PARTNERS | Series D |
| Anthem, Inc. | Series E |
| Parian Global Management LP | Series E |
| BLUE OX HEALTHCARE PARTNERS | Series E |
| Vivo Capital | Series E |
| aMoon Fund | Series E |
Zippia gives an in-depth look into the details of Sera Prognostics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sera Prognostics. The employee data is based on information from people who have self-reported their past or current employments at Sera Prognostics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Sera Prognostics. The data presented on this page does not represent the view of Sera Prognostics and its employees or that of Zippia.
Sera Prognostics may also be known as or be related to SERA PROGNOSTICS, INC., Sera Prognostics, Sera Prognostics Inc and Sera Prognostics, Inc.